Professional Documents
Culture Documents
Drug Cards PDF
Drug Cards PDF
Med Cards
Drug Med Cards
Table of Contents
1. Anti-
Viral .............................................................................
.............................................................. 5
2.
Benzodiazepenes ...................................................................
........................................................... 6
3.
Diuretics .........................................................................
................................................................... 8
4. Antiseizure
Meds ..............................................................................
................................................ 9
5. Vitamins and
Minerals ..........................................................................
.......................................... 13
6.
Steroid ...........................................................................
.................................................................. 14
7.
Opiod..............................................................................
................................................................. 15
8. Opiod
Antagonists........................................................................
................................................... 17
9.
NSAIDS ............................................................................
................................................................ 18
10. Analgesic,
Antipyretic .......................................................................
.............................................. 19
11.
Anticholinergic ...................................................................
............................................................. 20
12.
Bronchodilator ....................................................................
............................................................ 21
13. Thyroid Hormone
Replacement .......................................................................
............................... 22
14. Alpha Adronergic Receptor
Antagonist ........................................................................
.................. 23
15. Antiparkinson (Cholinergic Receptor
Antagonist.........................................................................
... 24
16. Fluid and
Electrolytes ......................................................................
................................................ 26
17.
Antibiotics .......................................................................
................................................................ 28
18. Cholesterol Lowering
Agents ............................................................................
.............................. 32
19. Laxatives/ Stool
Softeners..........................................................................
..................................... 34
20. Anti-
Diarrheal..........................................................................
........................................................ 36
21. Beta-
Blockers ..........................................................................
........................................................ 37
22.
Nitrates ..........................................................................
................................................................. 39
23. ACE-
Inhibitors ........................................................................
......................................................... 40
24. Calcium Channel
Blockers ..........................................................................
..................................... 41
25. Central Acting
Antihypertensive ..................................................................
................................... 42
26.
Antihypertensives .................................................................
.......................................................... 43
27.
Antipsychotics ....................................................................
............................................................. 44
28. Anti-
Coagulants ........................................................................
....................................................... 50
29.
Antiplatelets .....................................................................
............................................................... 51
30. Proton Pump
Inhibitor .........................................................................
........................................... 52
31. H2- Receptor
Antagonist ........................................................................
......................................... 53
32. Cerebral
Stimulant .........................................................................
................................................. 54
33.
Antihistamines ....................................................................
............................................................ 55
34.
Antidiabetic ......................................................................
............................................................... 57
35.
Antihypoglycemic ..................................................................
.......................................................... 60
36. Anti-
fungal.............................................................................
.......................................................... 61
37. Eye
Drops .............................................................................
........................................................... 62
38.
Antidepressant ....................................................................
............................................................ 63
39. Tricyclic
Antidepressants ...................................................................
............................................. 65
40. Selective Serotonin Reuptake Inhibitor
(SSRI) ............................................................................
.... 67
41. Monoamine Oxidase Inhibitors
(MAOIs) ...........................................................................
............. 69
42. Anti-
Emetic.............................................................................
......................................................... 70
43.
Antituberculosis ..................................................................
............................................................ 71
44. Substance Abuse
Deterrent .........................................................................
................................... 72
45. Bone Metabolism
Regulatory ........................................................................
................................. 73
46. Bacterial Collagenase
Enzyme.............................................................................
............................ 74
Bibliography ......................................................................
.......................................................................... 75
Mike Linares
Student Nurse Mentor & Certified EKG
Instructor
Before Helping Hundreds of Struggling Nursing Students Reach Graduation Day &
Before Becoming a
Student Nurse Mentor & Certified EKG Instructor, I Myself Was A Struggling "At
Risk" Student Nurse
Drowning In My Books & Lost In Clinical.
I was that struggling student working full time in the Emergency Room at one of
those
MEGA hospitals in Orange, California. I worked as an EMT aka a "medic" for 8 years
prior to failing out. I knew how to take care patients, I knew the basics of the
ABCs of
basic life support, I knew how to take vital signs and how to fix minor injuries. I
thought I
had enough experience to skate right through nursing school, I remember thinking
"how
hard can it be" right?
After two semesters, I FAILED out of the Program.
I felt defeated, depressed and like a loser. It was one of the lowest points of my
life.
Sitting in my room practically bawling my eyes out, I remember quotes my mom and
dad used to encourage me with, "son, whatever doesn´t kill you, Makes you Stronger"
&
" Failing is Not a Bad Thing, As long as learn, become better, and NEVER EVER QUIT"
Ending with:
"able to return next semester contingent upon
demonstrating INCREASED
COMPETANCIES in these core areas."
In a systematic way to put all the "core competencies" of nursing school that
instructors look for to pass
students. My quest was to make it SIMPLE first and foremost, by cutting out the
fluff and getting down to
the nitty critty making it easier.
At that moment I realized there are better, more predictable, and more low cost
ways to get higher test
scores and have more critical thinking skills than the money I had been spending on
dead end study
books that claimed to help but really just confuse me more.
I needed simplicity!!!
Within the next six months I had created over 27 different student help systems,
strategies and tactics
that produced better results for me - some better than others.
Then over the next few semesters I tracked, tested, and tweaked each system until
my students were
passing with a 82% or better on each and every test, 2 students being out of School
for over 25 years &
coming back to score 94% on their EKG cardiac test! Truly amazing & truly making me
proud to be their
mentor.
1. Anti-Viral
1.1. Acyclovir
(Zovirax)
Class: Antiviral
Actions: reduces viral shedding and formation of new lesions and speeds healing
time. Peak: 1.5-2hr.
Half-life: 2.5-5hr.
Indications: (IV treatment) viral encephalitis, herpes simplex, varicella-zoster
virus (shingles/chickpox);
(orally) herpes simplex, varicella-zoster virus; (topically) herpes labialis (cold
sores) and initial episodes of
herpes gentitalis
Norm. Dosage, Freq, Route, Range: PO 400mg bid Max: 800mg/day
Side Effects: headache, nausea, vomiting, diarrhea
Nursing Considerations: Monitor I&O & hydration status. Lab tests: baseline and
periodic renal function
tests
2. Benzodiazepenes
1.3. Alprazolam
(Xanax)
Class: Anxiolytic; Sedative-Hypnotic; Benzodiazepine
Actions: A CNS depressant that appears to act at the limbic, thalamic, and
hypothalamic levels of the
CNS. Has antianxiety and sedative effects w/ addictive potential. Peak: 1-2 hr.
Halh-life: 12-15 hr.
Indications: Anxiety Disorders, Panic Attacks
Norm. Dosage, Freq, Route, Range: PO 0.25-5 mg tid Max: 4 mg/day
Side Effects: Drowsiness, sedation
Nursing Considerations: Monitor S&S of drowsiness and sedation, especially in older
adults or the
debilitated, Lab tests: CBC, urinalysis and blood chemistry studies particularly
during continuing therapy
1.4. Diazepam
(Diastat, Valium)
Class: Benzodiazepine Anticonvulsant; Anxiolytic
Actions: Long-acting benzodiazepine psychotherapeutic agent. Benzodiazepines act at
the limbic.
Thalamic, and hypothalamic regions of the CNS and produce CNS depression resulting
in sedation, and
anticonvulsant activity dependent on the dosage. Onset: PO 30-60 min Peak: PO 1-2
hr Duration: IV 15
min-1 hr PO up to 3 hr
Indications: Status Epilepticus, Muscle Spasm, Anxiety, Alcohol Withdrawal, Pre-op
Norm. Dosage, Freq, Route, Range: IV/IM 5-10 m, repeat if needed at 10-15 min
intervals up to 30 mg,
then repeat if needed q2-4hr
Side Effects: Drowsiness, fatigue, confusion, vivid dreams, headache
Nursing Considerations: Monitor for adverse reactions, Monitor for therapeutic
effectiveness-max effect
may require 1-2 week, monitor for and report promptly signs of suicidal ideation
especially in those treated
for anxiety states accompanied by depression, observe patient closely and monitor
vital signs when
diazepam is given parentally; hypotension, muscular weakness, tachycardia, and
respiratory depression
may occur, Lab tests: periodic CBC and LFTs.
1.5. Lorazepam
(Ativan)
Class: Anxioltic; Sedative-Hypnotic; Benzodiazepine
Actions: most potent of the available benzodiazepine. Effects (antianxiety,
sedative, hypnotic, and skeletal
muscle relaxant) are mediated by the inhibition neurotransmitter GABA. Action sites
are thalamic,
hypothalamic, and limbic levels of CNS. Onset: IV 1-5 min. IM 15-30 min. Peak: IM
60-9 min. PO 2 hr
Duration 12-24 hr
Indications: Antianxiety, Insomnia, Premedication, Status Epilepticus
Norm. Dosage, Freq, Route, Range: PO 2-6 mg/day in divided doses Max: 10 mg/day
Side Effects: drowsiness, sedation, dizziness, weakness
Nursing Considerations: Supervise ambulation, Lab tests: Assess CBC and LFTs
periodically
Page 6 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
1.6. Temazepam
(Restoril)
Class: Benzodiazepine, Anxiolytic, Sedative-Hypnotic
Actions: reduces night awakenings and early morning awakenings; increases total
sleep times, absence
of rebound effects. Onset: 30-50 min. Peak: 2-3hr. Duration: 10-12hr. Half-life: 8-
24hr
Indications: to relieve insomnia
Norm. Dosage, Freq, Route, Range: PO 7.5-30mg at bedtime Max: 30mg/night
Side Effects: drowsiness, dizziness, lethargy
Nursing Considerations: hypersensitivity, Lab tests: LFTs and kidney function tests
during long-term use,
be aware of S&S of overdose: weakness, confusion, slurred speech, ataxia, coma w/
reduced or absent
reflexes, hypertension and respiratory depression
3. Diuretics
1.7. Furosemide
(Lasix)
Class: Loop diruetic
Actions: Inhibits NA & Cl reabsorption, ↑ urine, ↓ edema & intravascular
volume. Onset: PO 30-60min. IV
5 min Peak: PO 60-70min IV 20-60min. Duration: 2hr.
Indications: promote urine output & decrease edema associated w/ CHF, cirrhosis of
liver & kidney
disease, decrease CHF, decrease hypertension
Norm. Dosage, Freq, Route, Range: (Edema) PO: 20-80 mg in 1 or more divided doses
Max: 600 mg/day
(Hypertension) PO: 10-40 mg/kg bid Max: 480 mg/day
Side Effects: Circulatory collapse, hypokalemia, aplastic anemia, agranulocytosis
(rare)
Nursing Considerations: check K+ levels prior to adm., monitor I&O closely, rapid
acting doses to prevent
sleep disturbance, Potassium rich foods: bananas, oranges, dried dates, etc., CBC,
serum and urine
electrolytes, CO2 BUN, Blood Sugar, Uric Acid, Urine and Blood Glucose, HbA1C in
diabetic patients w/
decompensated hepatic cirrhosis, may cause hyperglycemia
1.8. Hydrochlorothiazide
(Microzide, Oretic)
Class: Electrolytic and Water Balance; Thiazide Diuretic
Actions: Therapeutic effectiveness is measured by decrease in edema and lowering of
blood pressure.
Onset: 2hr. Peak: 4hr. Duration: 6-12hr. Half-life: 45-120min.
Indications: adjunct treatment of edema associated with CHF, hepatic cirrhosis,
renal failure, and in the
management of hypertension
Norm. Dosage, Freq, Route, Range: PO 25-100mg/day in 1-3 divided doses Max:
200mg/day
Side Effects: Hyperglycemia, hyperuricemia, hypokalemia
Nursing Considerations: Check BP, monitor I&O and check for edema, Lab tests:
baseline and periodic
determinations of serum electrolytes, blood counts, BUN, blood glucose, uric acid,
CO2, are recommended.
1.9. Spironolactone
(Aldactone)
Class: Electrolytic and water balance; Aldosterone Antagonist; Potassium-Sparing
Diuretic
Actions: A diuretic agent that promotes sodium and chloride excretion w/o
concomitant loss of potassium.
Lowers systolic and diastolic pressures in hypertensive patients. Effective in
treatment of primary
aldosteronism. Onset: gradual Peak: 2-3days; Max effect may take up to 2 weeks
Duration: 2-3 days or
longer
Indications: Edema due to CHF, Hypertension, Primary Aldosteronism, Hypokalemia
Norm. Dosage, Freq, Route, Range: PO 25-400mg/day in divided doses Max: 400mg/day
Side Effects: fluid and electrolyte imbalance, nausea, vomiting
Nursing Considerations: check BP, lab tests: monitor serum electrolytes (Na and K),
assess for signs
and symptoms of fluid and electrolyte imbalance, monitor daily I&O and check for
edema
4. Antiseizure Meds
1.10. Carbamazepine
(Carbatrol, Tegretol, Epitol, Equetro, Mazepine)
Class: Anticonvulsant tricyclic
Actions: effective anticonvulsant for a range of seizure disorders and as an
adjuvant reduces depressive
S&S and stabilizes mood. Peak: 2-8hr. Half-life: variable due to autoinduction 25-
65hr. than 14-16he with
repeated use
Indications: Seizures; Trigeminal Neuralgia; Bipolar Disorder (Equetro)
Norm. Dosage, Freq, Route, Range: PO 200mg bid, gradually increase to
800-1200mg/day in 3-4 divided
doses Max: 1200mg/day
Side Effects: leukopenia, confusion, headache, dizziness
Nursing Considerations: Lab tests: baseline and periodic CBCs including platelets,
reticulocytes, serum
electrolytes and serum iron, LFTs, BUN and complete urinalysis, attempt a dosage
reduction after 3
months, monitor for toxicity, I&O and vital signs
1.11. Clonazepam
(Klonopin)
Class: Anticonvulsant; Benzodiazepine
Actions: Suppresses spike and wave discharge (petitmal) and decreases amplitude,
frequency, duration,
and spread of discharge in minor motor seizures. Onset: 60 min Peak: 1-2 hr
Duration up to 12 hr in adults;
6-8 hr in children
Indications: Seizures, Panic Disorders
Norm. Dosage, Freq, Route, Range: PO 1.5mg/day in 3 divided doses, increased by
0.5-1 q3days until
seizures are controlled or until intolerable adverse effects Max: 20 mg/day
Side Effects: Drowsiness, sedation, ataxia
Nursing Considerations: Monitor for signs of suicidal ideation in depressive
individuals, Lab tests:
periodic LFTs, platelet counts, blood counts, and renal function tests, Monitor for
S&S of overdose, including
somnolence, confusion, irritability, sweating, muscle and abdominal cramps,
diminished reflexes, coma.
1.12. Gabapentin
(Neurontin)
Class: Anticonvulsant; Gaba Analog
Actions: Used in conjunction with other anticonvulsants to control types of seizure
in patients with epilepsy.
Effective in controlling painful neuropathies
Indications: Seizure disorder, Past-Herpetic Neuralgia, Restless Leg Syndrome
Norm. Dosage, Freq, Route, Range: start at 300mg may slowly increase Max:
1,200mg/day
Side Effects: drowsiness, fatigue
Nursing Considerations: monitor for therapeutic effectiveness, may not occur until
several weeks
following initiation of therapy, monitor for and report dizziness, somnolence, or
other sign of CNS
depression
Simplenursing.com 60% Less Study Time, Less Stress More Success!
Page 9 of 75
Drug Med Cards
1.13. Lamotrigine
(Lamictal)
Class: Anticonvulsant
Actions: may act by inhibiting the release of glutamate and aspartate, excitatory
neurotransmitters at
voltage-sensitive sodium channels, resulting in decreased seizure activity in the
brain. Onset: 12wks. Peak:
1-4hr.
Indications: Seizures; Bipolar disorder
Norm. Dosage, Freq, Route, Range: PO start w/ 25mg daily for 2 wks, then 50mg daily
for 2 wks, then
100mg daily for 1 wk, then 200mg daily (low and slow)
Side Effects: dizziness, ataxia, somnolence, headache, nausea, diplopia, blurred
vision, Stevens-Johnson
syndrome, toxic epidermal necrolysis, rhinitis
Nursing Considerations: do not take med if skin rash develops, monitor pts. w/
bipolar disorder for
worsening of their symptoms and suicidal ideation, use protection from sunlight or
ultraviolet light until
tolerance is known
1.14. Levetiracetam
(Keppra)
Class: Anticonvulsant
Actions: The precise mechanism of antiepileptic effects is unknown. Peak: 1hr.
Indications: Partial onset Seizures; Tonic Clonic Seizures; Myoclonic Seizures
Norm. Dosage, Freq, Route, Range: PO/IV 500mg bid may increase by 500mg
bid q2wks. Max:
3,000mg/day or 1,000 mg/day ER tablet
Side Effects: Asthenia, headache, infection, somnolence, suicidal ideation
Nursing Considerations: Lab tests: periodic CBC w/ diff, Hct, and Hgb, LFTs;
monitor individuals w/ a
history of psychosis or depression for S&S of suicidal tendencies, suicidal
ideation, and suicidality
1.15. Oxcarbazepine
(Trileptal)
Class: Anticonvulsant
Actions: Anticonvulsant properties may result from blockage of voltage-sensitive
sodium channels, which
results in stabilization of hyper-excited neural membranes. Peak: steady-state
level reached in 2-3 days
Indications: Partial Seizures
Norm. Dosage, Freq, Route, Range: PO start w/ 300mg bid and increase by 600mg/day
qwk. To
2,400mg/day in 2 divided doses for monotherapy or 1,22mg/day as adjunctive therapy
Side Effects: fatigue, nausea, vomiting, abdominal pain, headache, dizziness,
somnolence, ataxia,
nystagmus, abnormal gait, Stevens-Johnson syndrome, toxic epidermal necrolysis,
diplopia, vertigo,
abnormal vision
Nursing Considerations: Monitor for & report S&S of hyponatremia or CNS impairment;
monitor
phenytoin levels; Lab tests: periodic serum sodium, T4 level; monitor plasma level
Page 10 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
1.16. Phenobarbital
(Solfoton)
Class: Anticonvulsant; Sedative-Hypnotic; Barbiturate
Actions: have anticonvulsant properties. Sedative and hypnotic effects appear to be
due primarily to
interference w/ impulse transmission of cerebral cortex by inhibition of reticular
activating system. Limiting
the spread of seizure activity results by increasing the threshold of motor cortex
stimulation. Peak: PO 8-
12 hr, IV 30 min Duration: IV 4-6 hr
Indications: Anticonvulsant, Status Epilepticus, Sedative/Hypmotic
Norm. Dosage, Freq, Route, Range: PO/IV 1-3 mg/kg/day in divided doses
Side Effects: Somnolence, nightmares, insomnia, “hangover”, headache, anxiety
Nursing Considerations: Observe patients receiving large doses for at least 30 min
to ensure that
sedation is not excessive, keep under observation, check IV site frequently,
monitor serum drug levels-
greater than 50 mcg/mL may cause coma, expect restlessness
1.17. Phenytoin
(Dilantin)
Class: Anticonvulsant; Hydantoin
Actions: Anticonvulsant action elevates the seizure threshold and/or limits the
spread of seizure discharge.
Accompanied by reduced voltage, frequency, and spread of electrical discharges w/in
the motor cortex.
Peak: Prompt Release: 1.5-3 hr Sustained Release: 4-12 hr
Indications: To control tonic-clonic (grand mal) seizures, psychomotor and
nonepileptic seizures (ex:
Reye’s syndrome). Used to prevent or treat seizures occurring during or
after neurosurgery. Not effective
for absence seizures.
Norm. Dosage, Freq, Route, Range: PO 15-20 mg/kg loading dose than 300 mg/day in 1-
3 divided doses,
may be gradually increased by 100 mg/week until seizures are controlled IV: 10-15
mg/kg then 300 mg/day
in divided doses
Side Effects: drowsiness, gingival hyperplasia, thrombocytopenia, leukopenia
Nursing Considerations: Monitor Vital signs, Lab tests: periodic serum phenytoin
concent., CBC w/
differential, platelet count, Hct, Hgb, serum glucose, serum calcium, serum
magnesium, and LFTs
1.18. Pregabalin
(Lyrica)
Class: Anticonvulsant; Gaba-analog; Analgesic/Miscellaneous; Anxiolytic
Actions: an analog of GABA that increases GABA levels and reduces calcium currents
in the calcium
channels of neurons. Peak: 1.5hr. Half-life:6hr.
Indications: management of neuropathic pain associated with diabetic peripheral
neuropathy or spinal
cord injury, adjunctive therapy for adult patietns w/ partial-onset seizures,
management of postherpetic
neuralgia, fibromyalgia
Norm. Dosage, Freq, Route, Range: PO 50-100mg tid Max: 300mg/day
Side Effects: accidental injury, ataxia, dizziness, somnlonce, peripheral edema,
weight gain, diplopia,
blurry vision
Nursing Considerations: Monitor for and report promptly mental status or behavior
changes (e.g.,
anxiety, panic attacks, restlessness, irritability, depression, suicidal thoughts).
Monitor for weight gain,
peripheral edema and S&S of heart failure. Monitor diabetics for increased
incidences of hypoglycemia.
1.19. Primidone
(Mysoline)
Class: Anticonvulsant; Barbiturate
Actions: effective as an anticonvulsant in all types of seizure disorders except
absent seizure. Peak: 4hr
Half-life: 3-24hr
Indications: management of complex partial and generalized tonic-clonic seizure
Norm. Dosage, Freq, Route, Range: PO 250mg/day increased by 250mg/wk Max: 2g/day in
2-4 divided
doses
Side Effects: drowsiness, sedation, vertigo, ataxia, headache, nausea, vomiting,
anorexia, leukopenia,
thrombocytopenia
Nursing Considerations: Lab tests: baseline and periodic CBC, complete blood
chemistry (q6mo), and
primidone blood levels (Therapeutic blood levels 5-10 mcg/mL). Monitor primidone
plasma levels
(concentrations greater than 10mcg/mL are usually associated w/ significant ataxia
and lethargy). Observe
for S&S of folic acid deficiency: mental dysfunction, psychiatric disorders,
neuropathy, and megaloblastic
anemia.
6. Steroid
1.23. Dexamethasone Sodium Phosphate
(Baycadron, Decadron, Dexamethasone)
Class: Adrenal Corticosteroid; Glucocorticoid
Actions: Long-acting synthetic adrenocorticoid with intense anti-inflammatory
activity and minimal
mineralocorticoid activity. Onset: Rapid Peak: PO 1-2 hr IM 8 hr Duration: PO 2.75
days IM 6 days Intra
lesional Intra-articular 1-3 weeks
Indications: Allergies, Inflammation, Neoplasias, Adrenocorticol Function
Abnormalities, Cerebral Edema,
Shock
Norm. Dosage, Freq, Route, Range: PO 0.25-4mg bid to qid IM 8-16mg q1-3weeks IV
0.75-0.9mg/kg/day
divided q6-12hr. Max: 16mg/day
Side Effects: Nasal Irritation, edema, hyperglycemia, impaired wound healing,
subacapsular cataract, oral
candidiasis
Nursing Considerations: take drug exactly as prescribed, report lack ir response to
med or malaise,
orthostatic hypotension, muscular weakness and pain, nausea, vomiting, anorexia,
hypoglycemic reaction,
or mental depression to prescriber, report any changes in appearance and easy
bruising
1.24. Fluticasone
(Flonase, Flovent)
Class: Synthetic steroids of glucocorticoid family of drugs
Actions: Fluticasone mimics the naturally-occurring hormone produced by the adrenal
glands, cortisol or
hydrocortisone. The exact mechanism of action of fluticasone is unknown.
Fluticasone has potent anti-
inflammatory actions. Onset: 1-3 wk. Peak: 4-8hr.
Indications: Seasonal allergy rhinitis
Norm. Dosage, Freq, Route, Range: Intranasal 100 mcg (1 inhalation) per nostril 1-2
times daily Max: 4
times daily
Side Effects: transient nasal irritation, burning, sneezing, epitaxis, bloody
mucous, nasopharyngeal
itching, dryness, crusting, and ulceration, headache, nausea, vomiting
Nursing Considerations: oral and nasal inhalers are not to be used interchangeably,
use of oral and
nasal inhaler provided by manufacturer should be carefully reviewed with patient
7. Opiod
1.26. Fentanyl
(Duragesic)
Class: Opioid Analgesic
Actions: Binds to opiate receptors in the CNS, alters response and perception of
pain. Onset: IV
immediate, IM min. Transdermal: 12-24hr. Peak: IV 3-5min. Transdermal: 24-72hrs.
Duration: IV 30-60min
IM 1-2hr. Transdermal 72hrs.
Indications: For moderate to severe chronic pain requiring continuous opioid
analgesic therapy.
Norm. Dosage, Freq, Route, Range: 25-100mcg/hr. for 72hr. transdermal patch
Side Effects: CNS depression, do not drink or eat grapefruit, polypharmacy
Nursing Considerations: BP, Pulse, Respirations <6 need Narcan
1.28. Hydromorphone
(Dilaudid)
Class: Narcotic, Analgesic
Actions: Potent opiate receptor agonist that does not alter pain threshold but
changes the perception of
pain in CNS. An effective narcotic analgesic that controls mild to moderate pain;
has antitussive properties.
Onset: IV 15min., PO 30min. Peak: 30-90min. Duration: 3-4hrs.
Indications: Relief of moderate to severe pain
Norm. Dosage, Freq, Route, Range: PO 2.5-10 mg q4-6hr Max: 60mg/day
SQ/IM/IV 0.75-2 mg q4-6hr Max: 12 mg/day
Side Effects: Nausea, vomiting, constipation, drowsiness, hypotension,
tachycardia, respiratory
depression
Nursing Considerations: Baseline respiratory rate, rhythm, and depth & size
of pupils;; respirations ↓
12/min. or less & mitosis are signs of toxicity, monitor vital signs at reg.
intervals, monitor I&O ratio & pattern
for urinary retention, monitor bowel pattern, √ for nausea/vomiting and
orthostatic hypotension.
1.30. Oxycontin
Class: Narcotic (opiate agonist); Analgesic
Actions: Semisynthetic derivative of an opium agonist the binds with stereo-
specific receptors in various
sites of CNS to alter both perception of pain and emotional response to pain.
Onset: 10-15 min. Peak: 30-
60 min. Duration: 4-5 hr.
Indications: Moderate to severe pain
Norm. Dosage, Freq, Route, Range: PO 5-10 mg q6hr (may titrate up to 10-30 mg q4hr
PRN) Immediate-
release 10 mg q12hr (may titrate up) Max: 180 mg/day
Side Effects: sedation, constipation, light-headedness, dizziness, fainting,
hepatotoxicity
Nursing Considerations: Monitor patient’s response closely, especially to
sustained-release preparations,
Lab tests: monitor LFTs and hematologic status periodically in patients on high
dose, evaluate patients
continued need
8. Opiod Antagonists
1.31. Naloxone
(Narcan)
Class: Opioid Antagonist
Actions: A potent narcotic antagonist, essentially free of agonistic (morphine-
like) properties. Reverses
the effects of opiates, including respiratory depression, sedation, and
hypotension. Onset: 2 min Duration:
45 min
Indications: Opiate Overdose
Norm. Dosage, Freq, Route, Range: IV 0.4-2mg, may repeat q2-3min up to 10mg if
necessary Max:
10mg
Side Effects: increased BP, tachycardia, nausea, vomiting
Nursing Considerations: Observe patient closely; duration of action of some
narcotics may exceed that
of naloxone. Keep prescriber informed
9. NSAIDS
1.33. Celecoxib
(Celebrex)
Class: Analgesic; NSAID; Cyclooxygenase-2 (Cox-2) Inhibitor; Anti-inflammatory
Actions: Exhibits anti-inflammatory; analgesic, and antipyretic activities. Reduces
or eliminates the pain
of rheumatoid and osteoarthritis. Peak: 3 hr
Indications: Osteoarthritis/Arthritis/Ankylosing Spondylitis, Rheumatoid Arthritis
Norm. Dosage, Freq, Route, Range: PO 100mg bid Max: 200mg
Side Effects: back pain, dizziness, headache, insomnia, diarrhea, abdominal pain
Nursing Considerations: Lab tests: periodically monitor Hct and Hgb, Lfts, BUN, and
Creatinine and
serum electrolytes, monitor closely lithium levels, monitor closely PT/INR, monitor
for fluid retention and
edema
1.34. Indomethacin
(Indocin)
Class: Analgesic, Non-steroidal Anti-inflammatory (NSAID)
Actions: It is a potent analgesic, anti-inflammatory, and antipyretic agent.
Promotes closure of persistent
patent ductus arteriosus. Onset 1-2 hr. Peak: 3 hr. Duration: 4-6 hr.
Indications: palliative treatment in active stages of moderate to severe rheumatoid
arthritis, ankylosing
rheumatoid spondylitis, acute gouty arthritis, and osteoarthritis of hip in
patients intolerant to or
unresponsive to adequate trials with salicylates and other therapy. Also used IV to
close patent ducus
arteriosus in the premature infant.
Norm. Dosage, Freq, Route, Range: PO/PR: 50 mg tid until pain is tolerable, then
rapidly taper Max: 150
mg/day
Side Effects: dizziness, tinnitus, nausea, vomiting
Nursing Considerations: Monitor for effectiveness, question patient carefully
regarding aspirin sensitivity
before initiation of therapy, observe patients carefully, Lab tests: monitor renal
function, LFTs, CBC w/
differential, BP and HR, visual and hearing acuity periodically
1.35. Ketorolac
(Acular, Acuvail, SPRIX)
Class: Analgesic, NSAID, Anti-inflammatory, Antipyretic
Actions: It inhibits synthesis of prostaglandins by inhibiting both COX-1 and COX-2
enzymes. Is a
peripherally acting analgesic. It inhibits platelet aggregation and prolongs
bleeding time. Peak: 46-60 min
Indications: Pain
Norm. Dosage, Freq, Route, Range: IV loading dose 30mg Max: 150mg/day on the first
day then
120mg/day subsequent days
Side Effects: drowsiness, nausea
Nursing Considerations: Lab tests: periodic serum electrolytes and LFTs; urinalysis
(for hematuria and
proteinuria) with long-term use, monitor urine output, monitor for S&S of GI
distress or bleeding including
nausea, GI pain, diarrhea, melena, or hematemesis, GI ulceration with perforation
can occur anytime during
treatment
1.38. Aspirin
(ASA)
Class: Non-narcotic, Antiplatelet, Antipyretic
Actions: inhibiting the formation of prostaglandins involved in the production of
inflammation, pain and
fever, powerfully inhibits platelet aggregation. High serum salicylate
concentrations can impair hepatic
synthesis of blood coagulation factors VII, IX, X. Peak: 15min-2hr.
Indications: Anti-inflammatory action, pain, fever reducer, antiplatelet
Norm. Dosage, Freq, Route, Range: PO: 350-650 mg q4h Max: 4 g/day
Side Effects: Bronchospasm, anaphylactic shock (laryngeal edema), nausea,
heartburn, stomach pains,
thrombocytopenia, hemolytic anemia
Nursing Considerations: Allergy to any ASA, monitor for salicylate toxicity. In
adults, a sensation of
fullness in the ears, tinnitus, and decreased or muffled hearing are the most
frequent symptoms.
11. Anticholinergic
1.39. Oxybutynin Cl
(Anutrol, Ditropan, Gelnique, Oxytrol)
Class: Anticholinergic; Antimuscaring; GU Antispasmodic
Actions: Synthetic tertiary amine that exerts direct antispasmodic action and
inhibits muscarinic effects of
acetylcholine on smooth muscle of the urinary muscle. Onset: 0.5-1hr. Peak: 3-6hrs.
Duration: 6-10hrs.
Indications: Overactive Bladder
Norm. Dosage, Freq, Route, Range: PO 5mg 2-4x/day Max: 20mg/day
Side Effects: drowsiness, blurred vision, dry mouth, constipation, pruritus at
application site (topical)
Nursing Considerations: periodic interruptions of therapy are recommended to
determine pt.’s need for
continued treatment, tolerance has occurred in some pt.’s;; keep
prescriber informed of expected responses
to drug therapy (e.g., effect on urinary frequency, urgency, urge incontinence,
nocturia, completeness of
bladder emptying)
1.40. Glycopyrrolate
(Robinul, Robinul Forte)
Class: Anticholinergic, Antimuscarinic, Antipasmodic
Actions: Inhibits motility of GI and genitourinary tract, it also decreases volume
of gastric and pancreatic
secretions, saliva, and perspiration. Onset: PO: 1 hr., IV: 1 min., IM/SQ: 15-30
min Peak: PO: 1 hr., IM/SQ:
30-45 min. Duration: PO: 8/12 hr., IM/SQ: 2-7 hr.
Indications: Adjunctive management of peptic ulcer and other GI disorders
associated with hyperacidity
Norm. Dosage, Freq, Route, Range: PO: 1 mg tid or 2 mg bid or tid in equally
divided intervals Max; 8
mg/day
Side Effects: Decreased sweating, Xerostomia, Urinary hesitancy or retention
Nursing Considerations: Monitor I&O ratio and pattern particularly in older adults,
Monitor vital signs,
especially when drug is given parenterally. Report any changes in heart rate and
rhythym.
12. Bronchodilator
1.41. Albuterol
(Proventil, Ventolin)
Class: Bronchodilator (Resp. Smooth Muscle Relaxant); Beta-Adrenergic Agonist
Actions: Bronchodilation decreased airway resistance; facilitates mucous drainage,
and increases vital
capacity. Onset: Inhaled 5-15 min PO 30 min Peak: 0.5-2 hr PO 2.5 hr Duration:
inhaled3-6 hr PO 4-6 hr
(8-12hr w/ sustained release)
Indications: Bronchospasm
Norm. Dosage, Freq, Route, Range: PO 2-4 times/day, 4-8 mg sustained release 2
times/day Inhaled:
1-2 inhalations q4-6hr
Side Effects: Tremor, anxiety, nervousness, headache, restlessness
Nursing Considerations: Monitor effectiveness, Monitor S&S of fine tremor in
fingers, Lab Tests: periodic
ABGs, PFTs, pulse oximetry
1.45. Donepezil
(Aricept)
Class: Central Acting Cholinergic; Cholinesterase Inhibitor
Actions: improves global function, cognition, and behavior of patients with mild to
moderate Alzheimer’s.
Peak: 3-4hr. Half-life: 70hr.
Indications: mild, moderate, or severe dementia of Alzheimer’s type.
Norm. Dosage, Freq, Route, Range: PO 5-10mg at bedtime Max: 10mg/day
Side Effects: headache, insomnia, nausea, diarrhea, vomiting, muscle cramps,
anorexia
Nursing Considerations: Monitor closely for S&S of GI ulceration and bleeding,
monitor cardiovascular
status, exercise caution
1.50. Ergocalciferol
(Calcidol, D-ViSol, Vitamin D2)
Class: Vitamin D Analog
Actions: distributed through the circulation and plays a major regulatory role.
Responsible for regulation
of serum calcium level.
Indications: Nutritional Rickets, Osteomalacia, Hypoparathyroidism
Norm. Dosage, Freq, Route, Range: PO 25-125 mcg/day for 6-12 weeks; may need to
increase to 7.5
mg/day in patients w/ malabsorption. Peak: after 4 weeks Duration: 2 months or
more.
Side Effects: fatigue, weakness, vertigo, tinnitus, ataxia, muscle and joint pain
Nursing Considerations: Monitor closely patients receiving therapeutic doses of
Vitamin D, must remain
under close medical supervision, Lab tests: Serum calcium, phosphorus, magnesium,
alkaline,
phosphatase, BUN, periodic urine calcium, casts, albumin, and RBC, Monitor for
hypercalcemia
17. Antibiotics
1.54. Amoxicillin & Clavulanic Acid
(Augmentin)
Class: Beta-Lactam, Antibiotic, Aminopenicillin
Actions: Inhibits the final stage of bacterial cell wall synthesis , which leads to
cell lysis and death. Peak:
1-2hrs.
Indications: Infections caused by susceptible beta-lactamase-producing organisms,
lower respiratory tract
infections, acute bacterial sinusitis, community acquired pneumonia, otitis media,
sinusitis, skin and skin
structure infections, UTI
Norm. Dosage, Freq, Route, Range: PO: 250-500 mg tablet Max:1500 mg/day
Side Effects: Diarrhea, agranulocytosis (rare)
Nursing Considerations: determine previous hypersensitivity reactions to
penicillins, cephalosporins and
other allergens prior to therapy, Lab tests: baseline C&S prior to initiation of
therapy; start drug pending
results, monitor for S&S of an urticarial rash (usually occurring within a few days
after start of drug)
suggestive of a hypersensitivity reaction, monitor for and report diarrhea which
may indicate
pseudomembranous colitis
1.55. Amoxicillin
(Amoxil)
Class: Antibiotic, Aminopenicillin
Actions: Inhibits the final stage of bacterial cell wall synthesis, which results
in bacterial cell lysis and
death. Active against both aerobic gram-positive & aerobic gram negative bacteria.
Onset: 1-2hr. Duration:
1-1.3hr.
Indications: mild to moderate infections of ear, nose, throat, GU tract, skin, and
soft tissue caused by
susceptible bacteria, used in uncomplicated Gonorrhea
Norm. Dosage, Freq, Route, Range: PO 250-500 mg q8h Max: 60-80 mg/kg/day
Side Effects: Anaphaylaxis, pseudomembranous colitis (rare), agranulocytosis
(rare), hypersensitivity
Nursing Considerations: determine previous hypersensitivity reactions to
penicillins, cephalosporins and
other allergens prior to therapy, Lab tests: Baseline C&S tests prior to initiation
of therapy; start drug
pending results, periodic assessment of renal, hepatic and hematologic functions w/
prolonged therapy.
1.56. Ampicillin
(Principen)
Class: Antibiotic; Aminopenicillin
Actions: A broad-spectrum, semi synthetic aminopenicillin that is bactericidal but
is inactivated by
penicillinase. Inhibits final stage of bacterial cell wall synthesis by binding to
specific penicillin-binding
proteins located inside the bacteria cell wall resulting in lysis and death of
bacteria. Peak: Immed. After IV
Duration: 6-8hrs.
Indications: Infections of the GU, respiratory and GI tracts, and skin and soft
tissues; gonococcal
infections, bacterial meningitis, otitis media, sinusitis and septicemia and for
prophylaxis of bacterial
endocarditis. Used parentally only for moderately severe to severe infections.
Norm. Dosage, Freq, Route, Range: PO/IV/IM 250-500 mg q6hr Max: 2000 mg/day
Side Effects: Diarrhea, nausea, vomiting, rash
1.62. Levofloxacin
(Levaquin, Iquix, Quixin)
Class: Quinolone Antibiotic
Actions: A broad-spectum fluoroquinolone antibiotic that inhibits DNA-gyrase, an
enzyme necessary for
bacterial replication, transcription, repair, and recombination. Peak: PO 1-2 hr.
Half-life: 6-8 hr.
Indications: treatment of maxillary sinusitis, acute exacerbations of bacterial
bronchitis, community-
acquired pneumonia, uncomplicated skin/skin structure infections, UTI, acute
pyelonephritis caused by
susceptible bacteria, acute bacterial sinusitis, chronic bacterial prostatitis, nd
bacterial conjunctivitis,
treatment of pneumonic and septicemic plague.
Norm. Dosage, Freq, Route, Range: PO: 500 mg q24hr x 10 days
Side Effects: abdominal pain, nausea, headache, depression
Nursing Considerations: Monitor for decreases pulse, perspiration, or pallor during
insertion. Keep
patient supine until these signs disappear, Monitor BP
1.63. Linezolid
(Zyvox)
Class: Oxazolidinone Antibiotic
Actions: Synthetic antibiotic that binds to a site on the 23S ribosomal RNA of
bacteria, which prevents the
bacterial RNA translation process, thus preventing further growth. Peak: PO 1-2 hr.
Half-life: 6-7 hr.
Indications: Vancomycin-Resistant Enterococcus faecium, Nosocomial
or community-acquired
pneumonia, complicated and uncomplicated skin infections
Norm. Dosage, Freq, Route, Range: PO/IV: 600 mg q12hr x 14-28 days Max: 1,200
mg/day
Side Effects: diarrhea, nausea, vomiting, constipation, taste alteration
Nursing Considerations: Monitor S&S of bleeding, hypertension, or pseudomembranous
colitis that
begins w/ diarrhea, Lab tests: CBC, platelet count, Hgb, and Hct
1.64. Ofloxacin
(Floxin)
Class: Quinolone Antibiotic
Actions: Inhibits DNA gyrase, an enzyme needed for bacterial DNA replication, broad
spectrum against
gram +&- most effective against gram – aerobic and anaerobic bacteria. Peak 1-2hr.
Half-life: 5-7.5hr.
Indications: Gonorrhea; Prosistitis; RTI (PO) OTIC (Tympanic) and Ocular; PID
Norm. Dosage, Freq, Route, Range: 0.3% Opthalmic solution 1-2GTTs q2-4hr, qid
0.3% Otic solution GTTS q12hr. x days
Side Effects: Dizziness, N&V, DTS menorrhea, menorrhagia, dysuria, urinary
frequency
Nursing Considerations: C&S, tendon PN, rash, seizures, S&S super infection
1.65. Vancomycin
(Vancocin)
Class: Antibiotic, Bacteriocidal
Actions: Active against many gram-positive organisms. Inhibits cell-wall
biosynthesis and alteration of
bacterial cell-membrane permeability and RNA synthesis. Peak: 30min after end of
infusion Half-life: 4-8hr.
Indications: Infections
Norm. Dosage, Freq, Route, Range: (C. Diff.) PO 125-500 mg q6h (Staph) PO 500 mg-2
g in 3-4 divided
doses x 7-10 days Max: 2 g/day
Side Effects: Nephrotoxicity leading to uremia, shock-like state, anaphylactoid
reaction w/ vascular
collapse, leukopenia, hypotension accompanied by flushing and erythematous rash on
face and upper body
(red-man syndrome) following rapid IV infusion
Nursing Considerations: Allergy, monitor BP and HR, take peak & trough levels,
assess hearing. Be
aware that serum levels of 60-80 mcg/ml are associated w/ ototoxicity, monitor I&O.
Oliguria or cloudy or
pink urine may be a sign of nephrotoxicity
1.67. Cholestyramine
(Questrane, Prevalite)
Class: Antilipemic; Bile Acid Sequestrant
Actions: increase fecal loss of bile acids, which leads to lowered serum total
cholesterol by decreasing
LDL cholesterol, and reducing bile acid deposit in dermal tissues.
Indications: as adjunct to diet therapy in management of patients w/ primary
hypercholesterolemia w/ a
significant risk of atherosclerotic heart disease and MI; for relief of pruritus
secondary to partial biliary stasis
Norm. Dosage, Freq, Route, Range: PO 4-8g bid to qid and before meals and at
bedtime Max: 32g/day
Side Effects: constipation, flatulence, abdominal pain
Nursing Considerations: Monitor for petechiae, ecchymoses, abnormal
bleeding from mucous
membranes, tarry stools
1.68. Fenofibrate
(Tricor)
Class: Antilipemic; Fibrate
Actions: Fibric acid derivative w/ lipid-regulating properties. Lowers plasma
triglycerides by inhibiting
triglycerides synthesis and, as a result, lowers VLDL production as well as
stimulates the catabolism of
triglyceride-rich lipoprotein. Produces a moderate increase of HDL cholesterol
levels in most patients.
Peak: 6-8 hr. Half-life: 20 hr.
Indications: Hypertriglyceridemia
Norm. Dosage, Freq, Route, Range: PO 43-200 mg/day depending on product Max: 200
mg/day
Side Effects: fatigue, headache, nausea, vomiting, flatulence, constipation
Nursing Considerations: La tests: periodically monitor lipid levels, LFTs, and CBC
w/ differential, assess
for muscle pain, tenderness or weakness and if present monitor CPK level.
1.69. Niacin
(Niacor, Niaspan)
Class: Vitamin B3; Antilipemic
Actions: produces vasodilation by direct action on vascular smooth muscles.
Inhibits hepatic synthesis
of VLDL, cholesterol, and triglyceride, and indirectly LDL.
Peak: 20-70 min. Half-life: 45 min.
Indications: Niacin deficiency, Pellagra, Hyperlipidemia
Norm. Dosage, Freq, Route, Range: PO 10-20 mg/day (Niacin Deficiency) 1.5-3g/day in
divided doses,
may increase up to 6 g/day if necessary (Hyperlipidemia) Max: 6 g/day
Side Effects: headache, tingling, flushing with sensation of warmth, bloating,
flatulence, itchy palms
Nursing Considerations: monitor therapeutic effectiveness, Lab tests: obtain
baseline and periodic blood
glucose and LFTs in patients receiving prolonged high dose therapy, monitor
diabetics, and monitor closely
for evidence of liver dysfunction
1.72. Lactulose
(Cephulac; Chronulac)
Class: Hyperosmotic Laxative; Neurologic
Actions: Osmotic effect on lactulose moves water from plasma to intestines,
softening stools, and
stimulates peristalsis by pressure from water content of stool.
Indications: Chronic Constipation, prevention and treatment of portal-systemic
encephalopathy (PSE)
including stages of hepatic precoma and come
Norm. Dosage, Freq, Route, Range: PO 30-60mL/day PRN Max: 60mL/day
Side Effects: diarrhea, nausea, vomiting, flatulence
Nursing Considerations: promote fluid intake (1,500-2,000mL/day or greater) during
drug therapy for
constipation
Page 34 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
1.73. Metoclopramide
(Metozolv, Reglan)
Class: GI Stimulant; Prokinetic agent
Actions: potent central dopamine receptor antagonist that increases resting tone of
esophageal sphincter,
and tone and amplitude of upper GI contractions. Thus gastric emptying and
intestinal transit are
accelerated. Antiemetic action results from druf-induced elevation of CTZ threshold
and enhanced gastric
emptying. Onset: 30-60 min. Peak: 1-2 hr.Duration: 1-3 hr.
Indications: GERD, Diabetic gastroparesis, Small –bowel intubation/Radiologic Exam,
Chemotherapy-
Induced Emesis, Postoperative Nausea/ Vomiting
Norm. Dosage, Freq, Route, Range: PO 10-15 mg qid before meals and at bedtime IM/IV
10 mg qid Max:
60 mg
Side Effects: mild sedation, fatigue, restlessness, diarrhea
Nursing Considerations: report S&S immediately, lab tests: periodic serum
electrolytes, monitor for
possible hypernatremia and hypokalemia, avoid alcohol and other CNS depressants,
avoid driving for a
few hours after drug admin.
1.75. Sennosides
(Senokot)
Class: Stimulant Laxative
Actions: Peristalsis stimulated by conversion of drug to active chemical. Onset: 6-
10hr; may take up to
24hr.
Indications: Acute constipation and preoperative and preradiographic bowel
evacuation
Norm. Dosage, Freq, Route, Range: PO 1-2 tabs at bedtime Max 4 tabs
Side Effects: nausea, abdominal cramps, flatulence, watery diarrhea
Nursing Considerations: Reduce dose in patients who experience considerable
abdominal cramping
20. Anti-Diarrheal
1.76. Diphenoxylate
(Diphenatol, Lofene, Lomanate)
Class: Antidiarrheal
Actions: reduces GI motility. Onset: 45-60 min Peak: 2hr. Duration: 3-4hr.
Indications: management of diarrhea
Norm. Dosage, Freq, Route, Range: PO 5-10mL 3-4 times daily Max: 40mL/day
Side Effects: hypersensitivity, flushing, palpitation, headache, dizziness
Nursing Considerations: Assess GI function, monitor for S&S of dehydration,
frequency and consistency
of stools
1.77. Loperamide
(Maalox, Imodium, Kaopectate, Pepto)
Class: Antidiarrheal
Actions: Inhibits GI peristaltic activity by direct action on circular and
longitudinal intestinal muscles.
Prolongs transit time of intestinal contents, increases consistency of stools, and
reduces fluid and
electrolyte loss. Onset: 30-60min. Peak: 2.5hrs (solution), 4-5hrs. (Capsules)
Duration: 4-5hrs.
Indications: Acute Diarrhea; Chronic Diarrhea
Norm. Dosage, Freq, Route, Range: PO 4mg followed by 2mg after each unformed stool
Max: 16mg/day
Side Effects: Toxic megacolon, abdominal pain or discomfort, constipation
Nursing Considerations: monitor fluid and electrolyte balance, record number and
consistency of stools
21. Beta-Blockers
1.78. Atenolol
(Tenormin)
Class: Beta-Adrenergic Antagonist; Antihypertensive
Actions: reduces rate & force of cardiac contractions (negative inotropic action);
cardiac output is reduced
as well as systolic and diastolic BP. Decreases peripheral vascular resistance both
at rest and with
exercise. Peak: 2-4hr. Duration: 24hr. Half-life: 6-7hr.
Indications: management of hypertension as a single agent or concomitantly w/ other
antihypertensive
agents, especially a diuretic, and in treatment of stable angina pectoris, MI
Norm. Dosage, Freq, Route, Range: PO 25-50mg/day, may increase to 100mg/day Max:
100mg/day
Side Effects: Bradycardia, hypotension, CHF, pulmonary edema, nausea, vomiting
Nursing Considerations: Measure trough BP, check apical pulse before admin.,
monitor BP, monitor
diabetics for loss of glycemic control
1.79. Carvedilol
(Coreg, Coreg CR)
Class: Alpha and Beta Adrenergic Antagonist; Antihypertensive
Actions: An effective antihypertensive agent reducing BP to normotensive range and
useful in managing
some angina, dysrhythmias, and CHF by decreasing myocardial oxygen demand and
lowering cardiac
workload. Peak: Antihypertensive effect 7-14 days
Indications: CHF, Left Ventricular Dysfunction, Post MI, Hypertension
Norm. Dosage, Freq, Route, Range: PO start w/ 3.125mg bid Max: 50mg/day
Side Effects: Dizziness
Nursing Considerations: Monitor for therapeutic effectiveness, lab tests: LFTs and
digoxin levels w/
concurrent use, monitor for worsening of symptoms in patients w/ PVD
1.81. Propanolol
(Inderal, InnoPran XL)
Class: Beta-Adrenergic Receptor Antagonist; Antihypertensive; Class II
Antiarrhythmic
Actions: Nonselective beta-blocker of both cardiac and bronchial adrenoreceptors
that competes w/
epinephrine and norepinephrine for available beta receptor sites. In higher doses,
it depresses cardiac
function including contractility and arrhythmias. Lowers both supine and standing
BP in hypertensive
patients. Peak: 60-90 min immediate release, 6 hr sustained release, IV 5 min
Indications: Hypertension, Angina, Arrhythmias, Acute MI, Migraine Prophylaxis
Norm. Dosage, Freq, Route, Range: PO 40 mg bid, usually need 160-480 mg/day Max:
480 mg/day
Side Effects: confusion, fatigue, drowsiness, bradycardia, paresthesia of hands
Nursing Considerations: Monitor apical pulse, respirations, BP and circulation to
extremities. Be aware
of adverse reactions, Lab tests: periodic hematologic, kidney, liver, and cardiac
functions, monitor I&O
1.82. Sotalol
(Betapace)
Class: Beta-Adrenergic Antagonist; Class II and III Antiarrhythmic
Actions: slows heart rate, decreases AV nodal conduction, and increases AV nodal
refractoriness.
Produces significant reduction in both systolic and diastolic blood pressure. Peak:
2-3 hr Duration: 24 hr
Indications: Ventricular Arrhythmias, Atrial Fibrillation/Flutter
Norm. Dosage, Freq, Route, Range: PO initial dose of 80 mg bid or 160 mg daily
taken prior to meals,
may increase every 3-4 days in 40-160 mg increments Max: 240 mg/day in 1-2 divided
doses
Side Effects: bradycardia, dyspnea, chest pain, palpation, fatigue, dizziness
Nursing Considerations: Monitor ECG baseline and periodically, Lab tests: baseline
serum electrolytes,
monitor cardiac status throughout therapy, monitor patients w/ bronchospastic
disease (ex: bronchitis,
emphysema) for inhibition of bronchodilation, monitor diabetics for loss of
glycemic control.
22. Nitrates
1.83. Isosorbide Dinitrate
(Dilatrate-SR, IsoBid)
Class: Nitrate Vasodilator (prototype: Nitroglycerin)
Actions: has an anti-anginal effect as a result of vasodilation of the coronary
arteries. Onset: SL 2-5min.
w/in 1hr. reg. tabs w/in 3 min. chewable tabs 30 min. sustained release tabs
Duration: SL 1-2hr. Chewable
tabs: 1.5-2hrs. Sustained release tabs: 6-8hrs.
Indications: relief of acute anginal attacks and for management of long-term angina
pectoris
Norm. Dosage, Freq, Route, Range: 5-30mg q2-3hr. Max: 360mg/day
Side Effects: light-headedness, flushing, headache, pallor
Nursing Considerations: Monitor for effectiveness, headaches tend to decrease in
intensity and
frequency with continued use, may produce tolerance
1.85. Nitroglycerin
(Nitro-Dur, Nitrostat, Nitroquick)
Class: Nitrate Vasodilator
Actions: Organic nitrate and potent vasodilator that relaxes vascular smooth
muscle. After conversion to
nitric oxide, it leads to dose-related dilation of both venous and arterial blood
vessels. Promotes peripheral
pooling of blood, reduction of peripheral resistance, and decreased venous return
to the heart. Both left
ventricular preload and afterload are reduced and myocardial oxygen consumption or
demand is
decreased. Onset: SL 2 min PO 3 min Ointment 30 min Duration: SL 30 min PO 3-5 hr
Ointment 3-6 hr
Indications: Angina
Norm. Dosage, Freq, Route, Range: SL 1-2 sprays (0.4-0.8 mg) or 0.3-0.6 mg tablet
q3-5min as needed
Max: 3 doses in 15 min PO 1.3-9 mg q8-12 hr Ointment apply 1.5-5 cm of ointment q4-
6hr
Side Effects: dizziness, headache, postural hypotension, Syncope, tachycardia
Nursing Considerations: Monitor BP, HR location, duration, pain
23. ACE-Inhibitors
1.86. Lisinopril
(Prinivil)
Class: Antihypertensive, ACE inhibitor
Actions: Lowers BP, improves cardiac output and exercise tolerance. Aldosterone is
also reduced, thus
permitting a potassium-sparing effect. Onset: 1 hr. Peak: 6-8hr. Duration: 24hrs.
Indications: Hypertension, Heart Failure
Norm. Dosage, Freq, Route, Range: (Hypertension) PO 10 mg once/day, may increase up
to 20-40 mg
1-2x/day (Heart Failure) PO 5-40 mg/day Max: 80 mg/day
Side Effects: Headache, dizziness, fatigue, hypotension, chest pain, nausea,
vomiting, diarrhea, anorexia,
constipation, intestinal angioedema, dyspnea, cough, rash, hyperkalemia, increase
BUN and creatinine
levels
Nursing Considerations: Check BP before giving med. With pt. in supine position,
monitor serum Na and
K+ levels, Lab tests: WBC q month for the first 3-6 months of therapy and at
periodic intervals for 1 yr.
1.87. Ramipril
(Altace)
Class: Angiotensin-Converting Enzyme (ACE) Inhibitor; Antihypertensive
Actions: lowers BP, and improves cardiac output as well as exercise tolerance.
Onset: 2hr Peak: 6-8hr
Duration: up to 24hr Half-life: 2-3hr
Indications:
Norm. Dosage, Freq, Route, Range: PO 2.5-5mg daily, may increase up to 20 mg/day in
1-2 divided
doses Max: 20mg/day
Side Effects:
Nursing Considerations: Monitor BP, Lab Tests: BUN and serum creatinine
periodically. Observe for
S&S of hyperkalemia
26. Antihypertensives
1.91. Losartan
(Cozaar)
Class: Angiotensin II Receptor Antagonist; Antihypertensive
Actions: Antihypertensive effect is due to vasodilation and inhibition of
aldosterone effects on sodium and
water retention. Peak: 6hr. Duration 24hr.
Indications: Hypertension
Norm. Dosage, Freq, Route, Range: PO 25-52mg in 1-2 divided doses Max: 100mg/day
Side Effects: dizziness, dyspepsia, insomnia, headache
Nursing Considerations: Monitor BP at drug trough, lab tests: monitor CBC,
electrolytes, liver and kidney
functions w/ long-term therapy
1.92. Valsartan
(Diovan)
Class: Renin Angiotensin System Antagonist; Antihypertensive
Actions: Blocks angiotensin II receptors results in vasodilation as well as
decreasing the aldosterone-
secreting effects of angiotensin II. These actions result in the antihypertensive
effect of valsartan. Onset:
BP decreased in 2 weeks. Peak: Plasma levels, 2-4hr; BP effect 4 weeks
Indications: Hypertension, Heart Failure
Norm. Dosage, Freq, Route, Range: PO 40-80mg daily Max: 320mg/day
Side Effects: headache, dizziness, nausea, vomiting
Nursing Considerations: monitor BP, lab tests: periodic LFTs, BUM, and creatinine,
serum potassium,
and CNC w/ differential
1.93. Terazosin
(Prazosin)
Class: Alpha-Adrenergic Receptor Antagonist, Antihypertensive
Actions: Selectively blocks Alpha1-adrenergic receptors in vascular smooth muscle
in many tissues,
including vascular smooth muscle, the bladder neck, and the prostate. Promotes
vasodilation, thus
producing relaxation that leads to reduction of peripheral vascular resistance and
lowers BP as well as
increased urine flow. Peak: 1-2 hr.
Indications: Hypertension, Benign Prostatic Hypertrophy
Norm. Dosage, Freq, Route, Range: PO start with 1 mg at bedtime, then 1-5 mg/day
Max: 20 mg/day
Side Effects: Asthenia (weakness), dizziness, headache, 1st –dose phenomenon
syncope
Nursing Considerations: Monitor BP, be alert for possible 1st –dose phenomenon
27. Antipsychotics
1.94. Aripiprazole
(Abilify)
Class: Atypical Antipsychotic; Dopamine System Stabilizer
Actions: combination of partial agonist activity at D2 and 5-HT1A receptors and
antagonists activity at 5-
HT2A receptors. Peak: 3-5hrs.
Indications: Schizpphrenia; Bipolar Mania; Agitation associated w/
Schizophrenia/Bipolar; Adjunct in Major
Depression; Irritability associated w/ Autism
Norm. Dosage, Freq, Route, Range: PO 10-15mg once daily, may increase at 2wk
intervals to Max:
30mg/day
Side Effects: headache, insomnia, light-headedness, somnolence, akathisia, risk of
stroke in elderly w/
dementia-related-psychosis, N&V, constipation
Nursing Considerations: monitor cardiovascular status, Lab tests: periodic Hct and
Hbg, and blood
glucose, monitor for elevated CPK and myoglobinuria if NMS is suspected.
1.95. Asenapine
(Saphris)
Class: Atypical Antipsychotic; Serotonin Antagonist; Antimanic; Antidepressant
Actions: thought to be related to antagonism to certain CND dopamine (D2) and
serotonin (5-HT2a)
receptors. Peak: 0.5-1.5hr.
Indications: Schizophrenia; Bipolar Disorder
Norm. Dosage, Freq, Route, Range: SL 5mg bid
Side Effects: Extrapyramidal symptoms (EPS), headache, somnolence, insomnia
Nursing Considerations: monitor BP, HR, and weight; monitor for orthostatic
hypotension; monitor
diabetes
1.96. Atomoxetine
(Strattera)
Class: Miscellaneous Psychotherapeutic
Actions: Selective inhibition of the presynaptic norepinephrine transporter,
resulting in norepinephrine
reuptake inhibition. Peak: 1-2hr.
Indications: Attention Deficit Hyperactivity Disorder (ADHD)
Norm. Dosage, Freq, Route, Range: PO start w/ 40mg in a.m., may increase after 3
days to target dose
of 80mg/day given either in a.m. or divided dose. May increase to 100mg/day if
needed.
Side Effects: headache, insomnia, suicidal ideation, upper abdominal pain, nausea,
vomiting, decreased
appetite, severe liver failure, and cough
Nursing Considerations: evaluate therapeutic effectiveness; report increased
aggression & irritability as
there may indicate need to d/c the drug; monitor children & adolescence for
behavior changes that may
indicate suicidal ideation; monitor cardiovascular status especially w/ preexisting
hypertension; monitor HR
& BP at baseline, following a dose increase, and periodically during therapy; Lab
tests: periodic LFTs
Page 44 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
1.97. Chlorpromazine
(Thorazine)
Class: Antipsychotic; Phenothiazine; Antiemetic
Actions: mechanism thought to be related to blockade of post-synaptic dopamine
receptors in the brain.
Onset: 30-60min. Peak: PO 2-4hr. IM 15-20min. Duration: 4-6hr.
Indications: Psychotic disorder, agitation; nausea and vomiting; dementia;
intractable hiccups; tetanus
Norm. Dosage, Freq, Route, Range: PO 25-100mg tid or qid, Max: 1,000mg/day IM/IV:
25-50mg Max:
600mg
Side Effects: Agranulocytosis,Neuroleptic malignant syndrome (NMS),
hypothermia,adynamic ileus,
sedation, extrapyramidal symptoms (EPS)
Nursing Considerations: Lab tests: LFTs, periodic CBC w/ diff, and blood glucose,
monitor cardiac status,
be alert for NMS and report immediately, report EPS, monitor BP frequently, may
cause pink to red-brown
discoloration of urine, have pt. wear protective clothing and sunscreen when
outdoors, have pt. practice
meticulous oral hygiene to prevent oral candidiasis
1.98. Clozapine
(Clozaril)
Class: Atypical Antipsychotic
Actions: Interferes w/ binding of dopamine to D1 and D2 receptors in the limbic
region of the brain. Onset:
2-4 wk. Peak: 2.5 hr.
Indications: Schizophrenia
Norm. Dosage, Freq, Route, Range: PO initiate 12.5mg daily or bid and increase by
25-50mg/day and
titrate to a target of 350-400mg/day in 3 divided doses Max: 900mg/day
Side Effects: tachycardia, agranulocytosis, transient fever, neuroleptic malignant
syndrome (NMS),
increased mortality from severe hematologic, cardiovascular, and respiratory
adverse effects.
Nursing Considerations: Lab tests: baseline WBC and absolute neutrophil count must
be made before
initial treatment q wk. for first 6 mon. then q2wk.for the next 6 mon. then
q4wk.periodic blood glucose,
monitor cardiovascular and respiratory status,
1.100. Haloperidol
(Haldol)
Class: Antipsychotic, Butyrophenone
Actions: Blocks postsynaptic dopamine receptors in the limbic system
of the brain. ↓ in dopamine
neurotransmission has been correlated w/ its higher instance of
extrapyramidal effects. ↓ Psychotic
manifestations & exerts strong antiemetic effect. Onset: IM 30-45min. Peak: PO 2-
6hr., IM 10-20min.
Indications: Management of manifestations of psychotic disorders & for control of
tics & vocal utterances
of Tourette’s syndrome, for treatment of agitated state is acute and
chronic psychoses.
Norm. Dosage, Freq, Route, Range: PO 0.2-5 mg bid or tid Max: 15 mg.day
IM 2-5 mg q4hr PRN Max: 30 mg/day
Side Effects: extrapyramidal reactions, tardive dyskinesia, agitation, drowsiness,
lethargy, fatigue, tremor,
ataxia, headache, confusion, vertigo, tachycardia
Nursing Considerations: monitor for drug effectiveness (long half-life), monitor
patients’ mental status
daily, be alert for behavioral changes
1.101. Iloperidone
(Fanapt)
Class: Atypical Antipsychotic
Actions: is both a dopamine (D2) and serotonin (5-HT2) antagonist. Peak: 2-4hr.
Indications: Schizophrenia
Norm. Dosage, Freq, Route, Range: PO initial 1mg big, then titrated to 6-12mg bid
Side Effects: dizziness, somnolence, tachycardia
Nursing Considerations: monitor for suicidal ideation, monitor BP, HR, and weight,
monitor for orthostatic
hypotension, Lab tests: baseline and periodic CBC w/ diff
1.103. Lurasidone
(Latuda)
Class: Atypical Antipsychotic
Actions: the mechanism of action is unknown but the efficacy of lurasidone in
schizophrenia is thought to
be mediated through central dopamine type 2 (D2) and serotonin Type 2 (5HT2a)
receptor antagonism.
Indications: Schizophrenia
Norm. Dosage, Freq, Route, Range: PO 40-160mg one daily
Side Effects: akathisia, dizziness, somnolence, parkinsonism, nausea
Nursing Considerations: monitor orthostatic VS, Lab tests: periodic blood glucose,
lipid profile, LFTs,
and CBC w/ diff, monitor closely pts. w/ neutropenia, monitor weight, monitor for
and report promptly seizure
activity, S&S of Neuroleptic Malignant Syndrome (NMS) or tardive dyskinesia
1.104. Olanzapine
(Zyprexa)
Class: Atypical Antipsychotic
Actions: thought to be due to antagonism for both serotonin 5-HT2A/2C and dopamine
D1-4 receptors.
Peak: 6hr.
Indications: Psychotic disorders; Bipolar Mania; Acute Agitation
Norm. Dosage, Freq, Route, Range: PO start w/ 5-10mg/day, may increase by 2.5-5mg q
wk. until desired
response Max: 20mg/day
Side Effects: weight gain, somnolence, dizziness, agitation, insomnia, headache,
nervousness, hostility,
Parkinsonism
Nursing Considerations: monitor cerebrovascular status closely, Lab tests:
periodically monitor ALT,
blood glucose, monitor BP and HR periodically and monitor temp.
1.105. Paliperidone
(Invega)
Class: Atypical Antipsychotic
Actions: Interferes w/ binding of dopamine to dopamine type 2 (D2) receptors,
serotonin (5-HT2a)
receptors and alpha-adrenergic receptors. Peak: 24hrs
Indications: Schizophrenia; Schizoaffective Disorder
Norm. Dosage, Freq, Route, Range: PO initially 6mg/day, may adjust up/down in 3mg
increments Max:
12mg/day
Side Effects: Akathisia, headache, somnolence
Nursing Considerations: Baseline ECG is recommended to rule out congenital long-QT
syndrome; Lab
tests: baseline and periodic serum electrolytes, periodic blood glucose, and CBC;
monitor diabetes and
loss of glycemic control
1.107. Quetiapine
(Seroquel)
Class: Atypical Antipsychotic
Actions: effectiveness indicated to a reduction in psychotic behavior. Peak: 1.5hr.
Half-life: 6hrs.
Indications: management of schizophrenia, maintenance of acute bipolar disorder,
and add-on therapy
for major depressive disorder
Norm. Dosage, Freq, Route, Range: 25-50mg dose and increase by 25-50mg/day Max:
800mg/day
Side Effects: dizziness, headache, somnolence, leukopenia
Nursing Considerations: Monitor for respiratory depression in patients with chronic
respiratory
insufficiency and suicidal tendencies
1.108. Risperidone
(Risperdol)
Class: Atypical Antipsychotic
Actions: interferes w/ binding of dopamine to D2-interlimbic region of the brain,
serotonin (5-HT2)
receptors, and alpha-adrenergic receptors in the occipital cortex. Onset:
therapeutic effect 1-2 wk. Peak: 1-
2hr.
Indications: Schizophrenia; Bipolar Disorder; Irritability Associated w/ Autism
Norm. Dosage, Freq, Route, Range: PO 1-2mg/day in 1 or 2 doses then titrate up Max:
8mg/day
Side Effects: sedation, drowsiness, headache, insomnia, agitation, extrapyramidal
symptoms (EPS),
neuroleptic malignant syndrome (NMS)
Nursing Considerations: monitor cardiovascular status closely, Lab tests: monitor
periodically blood
glucose, serum electrolytes, LFTs, and CBC, be aware of risk for orthostatic
hypotension
Page 48 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
28. Anti-Coagulants
1.112. Enoxaparin
(Lovenox)
Class: Anticoagulant; Low Molecular Weight Heparin
Actions: An effective anticoagulation agent, if is used for prophylactic treatment
as an antithrombotic agent
following certain types of surgery. Peak: 3 hr. Duration 4-6 hr.
Indications: Prevention of DVT after Hip or Knee Surgery, Prevention of DVT after
Abdominal Surgery,
Treatment of DVT and Pulmonary Embolus, Non-Q Wave MI Acute STEMI
Norm. Dosage, Freq, Route, Range: SQ 30 mg bid for 10-14 days starting 12-24 hr
post-surgery Max:
60 mg/day
Side Effects: Dyskinesia, Hyperkinesia, Nausea, Diarrhea, Urine discoloration
Nursing Considerations: Monitor carefully for hyperpyrexia, confusion, or
emergence of Parkinson’s S&S
during drug w/drawal, monitor for orthostatic hypotension and worsening of
dyskinesia, or hyperkinesia,
Lab tests: Hgb and serum ferritin levels w/ prolonged therapy
1.113. Heparin
(Heparin Sodium)
Class: Anticoagulant
Actions: Has rapid anticoagulant effect, does not lyse already existing thrombi but
may prevent their
extension & propagation. Onset: SQ 20-60min. Peak: in min. Duration: SQ 8-12hr. IV
2-6hr.
Indications: prophylaxis and treatment of venous thrombosis and pulmonary embolism
& to prevent
thromboembolic complications arising from cardiac & vascular surgery, frostbite, &
curing acute stage of
MI
Norm. Dosage, Freq, Route, Range: IV 5,000 units bolus dose then 20,000-40,000
units infused over
24hr, dose adjusted to maintain desired aPTT or 5,000-10,000 units IV piggyback q4-
6 hr Max: 60,000
units/day SQ 10,000-20,000 units/m2/24hr
Side Effects: spontaneous bleeding, fever, chills, numbness, elevated BP, headache
Nursing Considerations: Lab tests: baseline blood coag., Hct, Hgb, RBC, & platelet
count prior to admin.,
monitor aPTT levels closely, blood draw for coag. test 30 min before each scheduled
SQ or intermittent IV
dose, observe all needle sites daily, monitor vital signs
29. Antiplatelets
1.114. Aspirin
(ASA)
Class: Non-narcotic, Antiplatelet, Antipyretic
Actions: inhibiting the formation of prostaglandins involved in the production of
inflammation, pain and
fever, powerfully inhibits platelet aggregation. High serum salicylate
concentrations can impair hepatic
synthesis of blood coagulation factors VII, IX, X. Peak: 15min-2hr.
Indications: Anti-inflammatory action, pain, fever reducer, antiplatelet
Norm. Dosage, Freq, Route, Range: PO: 350-650 mg q4h Max: 4 g/day
Side Effects: Bronchospasm, anaphylactic shock (laryngeal edema), nausea,
heartburn, stomach pains,
thrombocytopenia, hemolytic anemia
Nursing Considerations: Allergy to any ASA, monitor for salicylate toxicity. In
adults, a sensation of
fullness in the ears, tinnitus, and decreased or muffled hearing are the most
frequent symptoms.
1.115. Clopidogrel
(Plavix)
Class: Antiplatelet
Actions: prolongs bleeding time, thereby reducing atherosclerotic events in high-
risk patients. Onset: 2hr.
reaches steady state in 3-7 days Half-life: 8hr.
Indications: acute coronary syndrome (ST or non-ST elevations). Secondary of MI,
stroke, and vascular
death
Norm. Dosage, Freq, Route, Range: PO 75mg/day Max: 75mg/day
Side Effects: fatigue, back pain, diarrhea, nausea, headache, dizziness
Nursing Considerations: Monitor for S&S of GI bleeding. Lab tests: platelet count,
and lipid profile
1.116. Dipyridamole
(Apo-Dipyridamole)
Class: Antiplatelet; Platelet Aggregate Inhibitor
Actions: Nonnitrate coronary vasodilator that increase coronary blood flow by
selectively dilating coronary
arteries, thereby increasing myocardial oxygen supply. Peak: 45-150 min.
Indications: Prevention of thromboembolism in cardiac valve replacement,
Thromboembolic Disorders,
Thallium Stress Test
Norm. Dosage, Freq, Route, Range: PO 150-400 mg/day in divided doses Max: 400
mg/day
Side Effects: headache, dizziness, faintness, syncope, weakness
Nursing Considerations: monitor therapeutic effectiveness
1.118. Pantoprazole
(Protonix)
Class: Gastric Proton Pump Inhibitor; Antisecretory
Actions: suppresses gastic acid secretion by inhibiting the acid (proton H+) pump
in the parietal cells.
Peak: 2-4hrs.
Indications: short-term treatment of erosive esophagitis associated w/
gastroesphageal reflux disease
(GERD), hyper secretory
Norm. Dosage, Freq, Route, Range: PO 40mg daily for 7-10days Max: 40mg/day
Side Effects: diarrhea, flatulence, abdominal pain, headache, insomnia, rash
Nursing Considerations: Lab tests: Urea breath test 4-6 wks after completion of
therapy. Monitor for
severe skin reaction
33. Antihistamines
1.122. Diphenhydramine
(Benadryl)
Class: Centrally acting cholinergic antagonist, Antihistamine, h1-receptor
antagonist
Actions: suppresses central cholinergic activity and prolongs action of dopamine by
inhibiting its reuptake
and storage. Onset: 15-30 min. Peak: 1-4hr. Duration: 4-7hr.
Indications: temporary symptomatic relief of various allergic conditions and to
treat or prevent motion
sickness, vertigo, and reactions to blood or plasma in susceptible patients
Norm. Dosage, Freq, Route, Range: PO 25-50mg tid or qid Max: 300mg/day IV/IM 10-
50mg q4-6hr Max:
400mg/day
Side Effects: drowsiness, tachycardia, dry mouth
Nursing Considerations: supervise ambulation, monitor cardiovascular status, do not
use with alcohol
and other CNS depressants, increase fluid intake
1.125. Promethazine
(Phenergan)
Class: Antihistamine, Antiemetic, Antivertigo
Actions: Long-acting derivative of phenothiazine with marked antihistamine activity
and prominent
sedative, amnesic, and anti-motion sickness actions. Onset: PO/PR/IM 20 min IV 5
min Duration: 2-8 hr
Indications: Motion sickness, nausea, pruritus sedation
Norm. Dosage, Freq, Route, Range: PO/PR 25mg q12hr Max: 50mg
Side Effects: drowsiness, blurred vision, dry mouth
Nursing Considerations: supervise ambulation, monitor respiratory function, drug
may suppress cough
reflex and cause thickening of bronchial secretions
34. Antidiabetic
1.126. Glipizide
(Glucotrol)
Class: Antidiabetic, Sulfonylurea
Actions: It lowers blood glucose level by stimulating pancreatic beta cells.
Glipizide improves postprandial
glycemic control. Onset: 15-30 min. Peak: 1-2 hr. Duration up to 24 hr.
Indications: Adjunct to diet for control of hyperglycemia in patient with type 2
diabetes mellitus.
Norm. Dosage, Freq, Route, Range: PO: 2.5-5 mg/day 30 min. before breakfast, may
increase by 2.5-5
mg q1-2 wk; greater than 15mg/day in divided doses before morning and evening meals
Max: 40 mg/day
Side Effects: hypoglycemia, anorexia, nausea, epigastric discomfort, heartburn,
diarrhea, allergic skin
reactions
Nursing Considerations: Observe for early signs of hypoglycemia, lab tests: monitor
fasting and
postprandial blood glucose, and periodic HgbA1C, LFTs, electrolytes and serum
osmolarity, must be made
aware of the potential for hypoglycemia responses.
1.127. Glyburide
(DiaBeta, Glynase)
Class: Antidiabetic; Sulfonylurea
Actions: One of the most potent of the 2nd generation sulfonylurea hypoglycemic
agents. Appears to lower
blood sugar concentration in both diabetic and nondiabetic individuals by
sensitizing pancreatic beta cells
to release insulin in the presence of elevated serum glucose levels. Onset: 15-
60min. Peak: 1-2hr.
Duration: up to 24hr. Half-life: 10hr.
Indications: adjunct to diet and exercise to lower blood glucose in patients with
type 2 diabetes mellitus.
Norm. Dosage, Freq, Route, Range: PO 1.25mg-5mg/day, may increase by 2.5-5mg q1-
2wk; greater
than 15mg/day should be given in divided doses with morning and evening meal Max:
20mg/day
Side Effects: hypoglycemia, nausea, vomiting, blurred vision
Nursing Considerations: Monitor blood glucose levels carefully, monitor at regular
intervals: Fasting and
postprandial blood glucose, HbA1C, and LFTs.
1.133. Metformin
(Glucophage)
Class: Antidiabetic; Biguanide
Actions: Effective in lowering serum glucose level and ultimately, the HbA1C valve.
Peak: 1-3hr. Half-life:
6.2-17.6hr.
Indications: treatment of type 2 diabetes mellitus as adjunct to diet and exercise
Norm. Dosage, Freq, Route, Range: PO start w/ 500mg daily tid or 850mg daily bid w/
meals, may
increase by 500-850mg/day q1-3wk Max: 2550mg/day
Side Effects: nausea, vomiting, abdominal pain, diarrhea, bitter or metallic taste,
bloatedness, anorexia
Nursing Considerations: Monitor vital signs and fasting and postprandial blood
glucose valves, monitor
cardiopulmonary status, Lab tests: baseline and periodic LFTs, kidney function
tests, hematologic
parameters for anemia, periodic fasting blood glucose, and HbA1C q3months.
35. Antihypoglycemic
1.134. Glucagon
(Glucagen)
Class: Antihypoglycemic
Actions: increases blood glucose secondary to gluconeogenesis, which is the
breakdown of glycogen in
the liver. Onset: 5-20 min. Peak: 30 min. Duration: 1-1.5hr. Half-life: 3-10 min.
Indications: hypoglycemia, radiologic studies of GI Tract
Norm. Dosage, Freq, Route, Range: IM/IV/SQ 1mg may repeat q5-20min if no response
for 1-2more
doses
Side Effects: nausea, vomiting, Stevens-Johnson syndrome
Nursing Considerations: be prepared to give IV glucose if patient fails to respond
to glucagon
36. Anti-fungal
1.135. Metronidazole
(Flagyl)
Class: Antitrichomonal; Amebicide
Actions: Has direct trichomonacidal and amebicial activity; exhibits antibacterial
activity against obligate
anaerobic bacilli, and Clostridia. Peak: 1-3 hr.
Indications: Trichomoniasis, Giardiasis, Amebiasis, Pseudomembranous Colitis,
Rosacea
Norm. Dosage, Freq, Route, Range: PO 7.5 mg/kg q6hr. IV Loading Dose 1.5 mg/kg IV
Maintenance
Dose 7.5 mg/kg q6hr. Max: 4 g/day
Side Effects: Candida, Nausea
Nursing Considerations: Discontinue therapy immediately if symptoms of CNS toxicity
develop, Monitor
for seizures and peripheral neuropathy, Lab tests: obtain total and differential
WBC count before, during,
and after therapy, monitor S&S of sodium retention, monitor patients on lithium,
report appearance of
candidiasis, repeat feces exam, usually up to 3 months to ensure that amebae have
been eliminated.
1.136. Ticonozole
(Monistat Cream)
Class: Anti-fungal
Actions: spectrum antifungal that inhibits the growth of yeast (Candida Albacans)
Indications: Vulvovaginal candidiasis
Norm. Dosage, Freq, Route, Range: 6.5% vaginal ointment, intra vaginal x1day (one
full applicator at
bed time)
Side Effects: mild erythema, burning, discomfort, rash, and itching
Nursing Considerations: monitor for sensitization, and allergic response.
38. Antidepressant
1.139. Bupropion HCL
(Wellbutrin, Zyban, Aplenzin, Budeprion)
Class: Antidepressant
Actions: The neurochemical mechanisms of bupropion is not fully understood. It
selectively inhibits the
neuronal reuptake of dopamine. Onset: 3-4wks. Peak: 1-3hrs.
Indications: Depression/Seasonal Affective Disorder
Norm. Dosage, Freq, Route, Range: PO 100mg tid (immediate release) or 150mg bid
(SR), or 300mg
daily (XL), doses greater than 450mg/day are associated w/ an increased risk of
adverse reactions including
seizures Max: 300mg/day
Side Effects: agitation, insomnia, dry mouth, blurred vision, headache, dizziness,
tremor, nausea,
vomiting, constipation.
Nursing Considerations: Lab tests: periodic renal function tests and LFTs; monitor
for and report
delusions, hallucinations, psychotic, episodes, confusion, and paranoia; report
significant restlessness,
agitation, anxiety, and insomnia; monitor weight weekly; report promptly suicidal
thoughts; do not take any
OTC drugs w/o consulting physician.
1.140. Desvenlafaxine
(Pristiq)
Class: Antidepressant; Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
Actions: Potent inhibitor of neuronal serotonin and norepinephrine reuptake. Onset:
2wks. Peak: 1-2hrs.
Duration: extensively tissue bound
Indications: Depression; Anxiety
Norm. Dosage, Freq, Route, Range: PO 25-125mg tid Max: 375mg/day
Side Effects: increased BP & HR, dizziness, somnolence, suicidality, nausea,
vomiting, dry mouth,
sweating
Nursing Considerations: Monitor for worsening of depression or emergence of
suicidal ideation; monitor
cardiovascular status periodically w/ measurements of BP & HR; Lab tests: periodic
lipid profile; monitor
neurologic status and report excessive anxiety, nervousness, and insomnia; monitor
weight periodically
and report excess weight loss; avoid using alcohol
1.141. Duloxetine
(Cymbalta)
Class: Antidepressant; Selective Serotonin Norepinephrine Reuptake Inhibitor
(SSNRI)
Actions: Causes potentiation of serotonergic and noradrenergic activity in the CNS.
Antidepressant and
antianxiety effects are presumed to be due to its dual inhibition of CNS
presynaptic neuronal uptake of
serotonin and norepinephrine, this increasing the serum levels of bith substances.
Peak: 6hrs.
Indications: Depression; Generalized Anxiety/Diabetic Neuropathy/Musculoskeletal
Pain; Fibromyalgia
Norm. Dosage, Freq, Route, Range: PO 40-60mg/day in 1-2 divided doses
Side Effects: insomnia, dry mouth, constipation
Nursing Considerations: Monitor for S&S of numerous drug-drug interactions; Lab
tests: LFTs for
unexplained abdominal pain or enlarged liver; monitor closely for and report
suicidal ideation; report
emergence of any of the following: anxiety, insomnia, agitation, panic attacks,
irritability, hostility,
psychomotor restlessness, hypomania, and mania
1.142. Mirtazapine
(Remeron)
Class: Tetracyclic Antidepressant; Anxiolytic
Actions: Acts as antidepressant. Effectiveness is indicated by mood elevation.
Peak: 2 hr.
Indications: Depression
Norm. Dosage, Freq, Route, Range: PO 15mg/day in a single dose at bedtime, may
increase Q1-2week
Max: 45mg/day
Side Effects: Somnolence, increased appetite, constipation, dry mouth
Nursing Considerations: Lab tests: monitor WBC count w/ differential, lipid
profile, and ALT/AST
periodically, monitor for worsening of depression or suicidal ideation, asses for
weight gain and excessive
somnolence or dizziness, monitor for orthostatic hypotension w/ a Hx of
cardiovascular disease or
cerebrovascular disease.
1.143. Trazadone
(Desyrel, Oleptro)
Class: Antidepressant
Actions: Centrally acting antidepressant that potentiates serotonin effects by
selectively blocking its
reuptake at presynaptic membranes in CNS. Onset: 1-2wks. Peak: 1-2hrs.
Indications: Depression
Norm. Dosage, Freq, Route, Range: PO 150mg/day in divided doses, may increase by
50mg/day q3-
4days Max: 400-600mg/day (Immediate release) PO 150mg/day may increase by 75mg/day
at 3 day
intervals Max: 375mg/day (Extended release)
Side Effects: drowsiness, hypotension (including orthostatic hypotension), dry
mouth
Nursing Considerations: Monitor BP & HR & rhythm; monitor for orthostatic
hypotension; be aware that
overdose is characterized by an extension of common adverse effects: vomiting,
lethargy, drowsiness, and
exaggerated anticholinergic effects.
1.144. Venlafaxine
(Effexor)
Class: Antidepressant; Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
Actions: Potent inhibitor of neuronal serotonin and norepinephrine reuptake. Onset:
2wks. Peak: 1-2hrs.
Duration: extensively tissue bound
Indications: Depression; Anxiety
Norm. Dosage, Freq, Route, Range: PO 25-125mg tid Max: 375mg/day
Side Effects: increased BP & HR, dizziness, somnolence, suicidality, nausea,
vomiting, dry mouth,
sweating
Nursing Considerations: Monitor for worsening of depression or emergence of
suicidal ideation; monitor
cardiovascular status periodically w/ measurements of BP & HR; Lab tests: periodic
lipid profile; monitor
neurologic status and report excessive anxiety, nervousness, and insomnia; monitor
weight periodically
and report excess weight loss; avoid using alcohol
Page 64 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
1.152. Paroxetine
(Paxil, Pexeva)
Class: Antidepressant; Selective Serotonin Reuptake Inhibitor (SSRI)
Actions: It is highly potent and a highly selective inhibitor of serotonin reuptake
by neurons in CNS. Onset:
2wks. Peak: 5-8hrs.
Indications: Depression; OCD; Panic Attacks; Social Anxiety; Generalized Anxiety,
PTSD; Premenstrual
Dysphoric Disorder
Norm. Dosage, Freq, Route, Range: PO 10-50mg/day Max: 80mg/day
Side Effects: Headache, sedation, nausea, dry mouth
Nursing Considerations: monitor for worsening of depression or emergence of
suicidal ideation; monitor
for significant weight loss; monitor pt. w/ history of mania for reactivation of
condition; monitor pts. w/
preexisting cardiovascular disease carefully because paroxetine may adversely
affect hemodynamics
status
1.154. Vilazodone
(Vibryd)
Class: Selective Serotonin Reuptake Inhibitor (SSRI); Psychotherapeutic Agent;
Antidepressant
Actions: Antidepressant is presumed to be linked to inhibition of CNS neuronal
uptake of the
neurotransmitter, serotonin. Peak: 4-5hrs.
Indications: Major Depressive Disorder
Norm. Dosage, Freq, Route, Range: PO initial dose of 10mg/day for 7 days, increase
to 20mg/day for 7
days, then to 40mg/day
Side Effects: dizziness, diarrhea, nausea
Nursing Considerations: monitor for worsening of depression or emergence of
suicidal ideation; supervise
pts. Closely who are high suicide risks; do not stop medication abruptly
Page 68 of 75 Simplenursing.com 60% Less Study Time, Less
Stress More Success!
Drug Med Cards
42. Anti-Emetic
1.158. Ondansetron HCL
(Zofran)
Class: 5-HT3 Anatagonist, Antiemetic
Actions: Prevents nausea and vomiting associated with cancer chemotherapy and
anesthesia. Peak: 1-
1.5hr Half-life: 3hr
Indications: prevention of nausea and vomiting associated with initiation and
repeated courses of cancer
chemotherapy, including high-dose cisplatin; postoperative nausea and vomiting
Norm. Dosage, Freq, Route, Range: PO 8-24mg 30 min before chemotherapy, than q8hr
times 2 more
doses
Side Effects: headache, sedation, diarrhea
Nursing Considerations: monitor fluid and electrolyte status, cardiovascular status
43. Antituberculosis
1.159. Isoniazid
(INH, Laniazid)
Class: Anti-infective; Antituberculosis
Actions: Exerts bacteriostatic action against actively growing tubercle bacilli,
may be bactericidal in higher
concentrations. Peak: 1-2 hr
Indications: Treatment of Active Tuberculosis, preventative therapy
Norm. Dosage, Freq, Route, Range: PO/IM 5mg/kg Max: 300 mg/day
Side Effects: Paresthesias, peripheral neuropathy, hepatotoxicity (elevated AST,
ALT; bilirubinemia;
jaundice; hepatitis)
Nursing Considerations: Monitor for therapeutic effectiveness, w/hold drug and
notify prescriber
immediately of a hypersensitivity reaction, Lab tests: monitor LFTs periodically,
monitor for and report signs
of hepatotoxicity, monitor BP, check weight at least twice weekly under standard
conditions
1.161. Antabuse
Class: Enzyme Inhibitor; Anti-Alcoholic Agent
Actions: Acts as a deterrent to alcohol ingestion by inhibiting the enzyme
acetaldehyde dehydrogenase,
which normally metabolizes alcohol in the body. Onset: Up to 12hr. Duration: Up to
2wk. Onset: Up to 12hr.
Duration: Up to 2wk.
Indications: Alcoholism
Norm. Dosage, Freq, Route, Range: PO 500mg/day for 1-2wk, then 125-500mg/day Max:
500mg/day
Side Effects: marked respiratory depression, unconsciousness, convulsions, sudden
death, hepatotoxicity
Nursing Considerations: Lab tests: baseline & follow-up transaminase studies every
10-14 days to detect
hepatic dysfunction; treat pt. w/ severe disulfiram reaction as though in shock,
monitor potassium levels,
especially if pt. has diabetes mellitus; explain the danger of alcohol ingestion
during treatment to pt.; report
promptly to prescriber the onset of nausea w/ RUQ pain or discomfort, itching,
jaundiced sclera or skin,
dark urine or clay-colored stools, w/hold drug pending LFTs
Bibliography
Ebersole, P., Hess, P., Touhy, T.A., Schmidt Logan, A., & Jett, K. (2008) Toward
healthy aging: Human
needs and nursing response ( 7th ed.). St. Louis, MO: Mosby.
Eliopoulous C. (2009). Gerontological nursing. ( 7th ed.). Philadelphia, PA:
Lippincott Williams & Wilkins.
Grodner, M., Long, S., & Walkingshaw,B.C. (2007). Foundations and clinical
application of nutrition: A
nursing approach ( 4th ed.). St. Louis, MO: Mosby.
Ignatavicius, D. D., & Workman, M. L. (2010). Medical-Surgical nursing (6th ed.).
St. Louis, MO:
Saunders.
Lowdermilk, D.L.,& Perry, S.E. ( 2007) . Maternity & women’s health care
(9th ed.). St. Louis, MO: Mosby.
Lehne, R.A. (2010). Pharmacology for nursing care (7th ed.). St. Louis, MO:
Saunders.
Lilley, L. L., Harrington, S., & Snyder, J.S. (2007). Pharmacology and the nursing
process (5th ED.). St.
Louis, MO: Mosby.
Roach, S. S.,& Ford, S. M. (2008). Introductory clinical pharmacology.
Philadelphia, PA: Lippincott
Williams & Wilkins.
Smeltzer, S. C., Bare, B.G., Hinkle, J. L., & Cheever, K.H. ( 2008).
Brunner and Suddarth’s textbook of
medical-surgical nursing ( 11th ed.). Philadelphia, PA: Lippincott Williams &
Wilkins.
Actions: reduces viral shedding and formation of new lesions and speeds healing
Actions: Because Amantadine does not suppress antibody formation, it can be
time. Peak: 1.5-2hr. Half-life: 2.5-5hr.
administered for interim protection in combination w/ influenza. Onset: w/in 48hrs.
Peak: 1-4hrs
Indications: (IV treatment) viral encephalitis, herpes simplex, varicella-zoster
virus
(shingles/chickpox); (orally) herpes simplex, varicella-zoster virus; (topically)
herpes Indications: Influenza A Treatment; Influenza A Preventative;
Parkinsonism; Drug-
labialis (cold sores) and initial episodes of herpes gentitalis
Induced Extrapyramidal Symptoms (EPS)
leukopenia
Nursing Considerations: Monitor I&O & hydration status. Lab tests: baseline and
periodic renal function tests
Nursing Considerations: Lab tests: pH and serum electrolytes; monitor and report
Actions: A CNS depressant that appears to act at the limbic, thalamic, and
Actions: Long-acting benzodiazepine psychotherapeutic agent. Benzodiazepines act
hypothalamic levels of the CNS. Has antianxiety and sedative effects w/ addictive
at the limbic. Thalamic, and hypothalamic regions of the CNS and produce CNS
potential. Peak: 1-2 hr. Halh-life: 12-15 hr.
depression resulting in sedation, and anticonvulsant activity dependent on the
Norm. Dosage, Freq, Route, Range: IV/IM 5-10 m, repeat if needed at 10-15 min
Side Effects: Drowsiness, sedation
intervals up to 30 mg, then repeat if needed q2-4hr
effectiveness-max effect may require 1-2 week, monitor for and report promptly
by depression, observe patient closely and monitor vital signs when diazepam is
Lorazepam
Temazepam
(Ativan)
(Restoril)
Class: Anxioltic; Sedative-Hypnotic; Benzodiazepine
Class: Benzodiazepine, Anxiolytic, Sedative-Hypnotic